Morgan Stanley Emergent Bio Solutions Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,226,985 shares of EBS stock, worth $9.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,226,985

Previous 1,223,021 0.32%

Holding current value

$9.46 Million

Previous $10.2 Million 14.86%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.72 - $11.97 $30,602 - $47,449	3,964 Added 0.32%	1,226,985 $11.7 Million
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $109,343 - $282,343	-19,116 Reduced 1.54%	1,223,021 $10.2 Million
Q2 2024 Oct 17, 2024	SELL	$1.86 - $6.98 $95,910 - $359,923	-51,565 Reduced 3.99%	1,242,137 $8.47 Million
Q2 2024 Aug 14, 2024	SELL	$1.86 - $6.98 $95,910 - $359,923	-51,565 Reduced 3.99%	1,242,137 $8.47 Million
Q1 2024 Oct 17, 2024	BUY	$1.5 - $3.41 $77,347 - $175,836	51,565 Added 4.15%	1,293,702 $3.27 Million
Q1 2024 Aug 16, 2024	BUY	$1.5 - $3.41 $87,519 - $198,959	58,346 Added 4.72%	1,293,702 $3.27 Million
Q1 2024 May 15, 2024	BUY	$1.5 - $3.41 $87,519 - $198,959	58,346 Added 4.72%	1,293,702 $3.27 Million
Q4 2023 Aug 16, 2024	SELL	$1.82 - $3.16 $12,341 - $21,427	-6,781 Reduced 0.55%	1,235,356 $2.96 Million
Q4 2023 Feb 13, 2024	BUY	$1.82 - $3.16 $1.14 Million - $1.98 Million	625,316 Added 102.5%	1,235,356 $2.96 Million
Q3 2023 Nov 15, 2023	BUY	$3.17 - $7.91 $84,860 - $211,750	26,770 Added 4.59%	610,040 $2.07 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $595,533 - $1.07 Million	81,025 Added 16.13%	583,270 $4.29 Million
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $1.18 Million - $2.47 Million	-151,499 Reduced 23.17%	502,245 $5.2 Million
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $3.59 Million - $7 Million	326,175 Added 99.57%	653,744 $7.72 Million
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $7.48 Million - $13.3 Million	-372,534 Reduced 53.21%	327,569 $6.88 Million
Q2 2022 Oct 27, 2022	BUY	$27.42 - $43.63 $7.2 Million - $11.5 Million	262,451 Added 59.97%	700,103 $21.7 Million
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $7.2 Million - $11.5 Million	262,451 Added 59.97%	700,103 $21.7 Million
Q1 2022 Oct 27, 2022	SELL	$36.48 - $52.22 $9.57 Million - $13.7 Million	-262,451 Reduced 37.49%	437,652 $18 Million
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $6.96 Million - $9.97 Million	190,845 Added 77.33%	437,652 $18 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $1.62 Million - $2.68 Million	-48,777 Reduced 16.5%	246,807 $10.7 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $14.8 Million - $19.5 Million	295,584 New	295,584 $14.8 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account